Skip to main content
Clinical Trials/NCT02775409
NCT02775409
Completed
Not Applicable

Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction

Mayo Clinic1 site in 1 country200 target enrollmentMay 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Reconstruction Following Mastectomy
Sponsor
Mayo Clinic
Enrollment
200
Locations
1
Primary Endpoint
Change in patient satisfaction
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study is for women scheduled to have immediate breast reconstruction following mastectomy using a tissue expander. The primary purpose of this study is to learn whether there are differences in the outcome between placing the tissue expander above the muscle or below the muscle. The study will evaluate pain, wellbeing, and overall satisfaction with reconstruction. A secondary purpose is to learn whether there are differences in complications and costs between the two locations.

Registry
clinicaltrials.gov
Start Date
May 1, 2016
End Date
February 6, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Minh-Doan Nguyen

Assistant Professor of Plastic Surgery

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Women at least 18 years of age, who will undergo immediate unilateral or bilateral implant-based breast reconstruction following therapeutic skin-sparing or nipple-sparing mastectomy.
  • Women at least 18 years of age, who will undergo immediate bilateral implant-based breast reconstruction following risk-reduction (prophylactic) skin-sparing or nipple-sparing mastectomy.

Exclusion Criteria

  • Subjects who are unable to read or speak English.
  • Patients desiring autologous reconstruction.
  • History of radiation therapy to the breast(s), e.g. history of breast conservation therapy.
  • Current nicotine and/or tobacco use.
  • Documented diagnosis of chronic pain.
  • Women who are pregnant or breast-feeding \*
  • Women who decline the use of acellular dermal matrix (ADM).
  • Surgeon decision not to proceed with tissue expander reconstruction.
  • Women undergoing single stage (straight to implant) reconstruction.

Outcomes

Primary Outcomes

Change in patient satisfaction

Time Frame: Baseline, Year 3

Difference in patient satisfaction between the two groups using the physical well being scale.

Study Sites (1)

Loading locations...

Similar Trials